Myriad Genetics, Inc. (MYGN) Tops Q4 EPS by 9c; Guides Above the Street
Tweet Send to a Friend
Myriad Genetics, Inc. (NASDAQ: MYGN) reported Q4 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
